Drugs / ATG Thymoglobulin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT01949129 Background | Apr 2013 → Jun 2025 overdue | acute lymphoblastic leukemia | St. Anna Children's Cancer Research | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATG Thymoglobulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01949129 ↗ |
| Modality | Protein / enzyme biologic | “Anti-human T-lymphocyte immunoglobulin” NCT01949129 ↗ |